Bausch & Lomb Will Review Company Operations at Morgan Stanley's Inaugural Healthcare Conference on May 2, 2003.Business Editors/Health/Medical Writers ROCHESTER, N.Y.--(BUSINESS WIRE)--April 28, 2003 Bausch & Lomb (NYSE NYSE See: New York Stock Exchange :BOL BOL Bolivia (ISO Country code) BOL Books Online BOL Bole (SIL code, Nigeria) BOL Bill Of Lading BOL Beginning Of Line BOL Best Of Luck BOL Buzz Out Loud BOL Bruin Online BOL Beginning Of Life ) announced today that its Chairman and Chief Executive Officer, Ronald L. Zarrella, and Chief Financial Officer, Stephen C. McCluski, will be participating in a discussion regarding the Company's operations at the Morgan Stanley The audio of the discussion will be posted on the Investor Relations Investor relations The process by which the corporation communicates with its investors. page of the Company's web site, www.bausch.com, following the conference. Bausch & Lomb is the eye health company, dedicated to perfecting vision and enhancing life for consumers around the world. Its core businesses include soft and rigid gas permeable contact lenses and lens care products, and ophthalmic surgical and pharmaceutical products. The Bausch & Lomb name is one of the best known and most respected healthcare brands in the world. Celebrating its 150th anniversary in 2003, the company is headquartered in Rochester, New York This article is about the city of Rochester in Monroe County. For the town in Ulster County, see Rochester, Ulster County, New York. Rochester, once known as The Flour City, and more recently as The Flower City or . Bausch & Lomb's 2002 revenues were $1.8 billion; it employs approximately 11,500 people worldwide and its products are available in more than 100 countries. More information about the company can be found on the Bausch & Lomb Web site at www.bausch.com. |
|
||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion